In NSCLC, the downregulation or loss of CDH1 (Fan et al., 2019; Lofiego et al., 2021) and upregulation of CDH2 is frequently observed and is associated with increased invasiveness and the ability of tumor cells to detach from the primary tumor site. Here, CDH2 is linked to non-small cell lung carcinoma.